These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38171626)

  • 1. Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.
    Marquette A; Iraniparast M; Hammond D
    BMJ Open; 2024 Jan; 14(1):e077908. PubMed ID: 38171626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.
    Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W
    Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of problematic cannabis use in Canada pre- and post-legalisation: Differences by neighbourhood deprivation, individual socioeconomic factors and race/ethnicity.
    Fataar F; Driezen P; Owusu-Bempah A; Hammond D
    Drug Alcohol Rev; 2023 Sep; 42(6):1534-1546. PubMed ID: 37137866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in cannabis-related emergency department visits across depressed and non-depressed individuals and the impact of recreational cannabis policy in Ontario, Canada.
    Kim C; Dusing GJ; Nielsen A; MacMaster FP; Rittenbach K; Allin S; O'Campo P; Penney TL; Hamilton HA; Kirst M; Chum A
    Psychol Med; 2023 Nov; 53(15):7127-7137. PubMed ID: 37345465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use prior to legalisation among alcohol consumers in the Canadian Yukon and Northwest territories.
    Hammond D; Goodman S; Hobin E
    Int J Circumpolar Health; 2021 Dec; 80(1):1948254. PubMed ID: 34278981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review.
    Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T
    Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.
    Wadsworth E; Rynard V; Driezen P; Freeman TP; Rychert M; Wilkins C; Hall W; Gabrys R; Hammond D
    Harm Reduct J; 2023 Feb; 20(1):19. PubMed ID: 36803833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cannabis legalisation on patterns of cannabis consumption among adolescents in Ontario, Canada (2001-2019).
    Imtiaz S; Nigatu YT; Sanches M; Ali F; Boak A; Douglas L; Hamilton HA; Rehm J; Rueda S; Schwartz RM; Wells S; Elton-Marshall T
    Drug Alcohol Rev; 2024 Mar; 43(3):764-774. PubMed ID: 38015010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis use and workplace cannabis availability, perceptions and policies among Canadian workers: a comparison before and after the legalisation of non-medical cannabis.
    Carnide N; Lee H; Landsman V; Frone MR; Furlan AD; Smith PM
    Occup Environ Med; 2022 Jul; 79(12):824-30. PubMed ID: 35851324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada.
    Leung J; Chan G; Stjepanović D; Chung JYC; Hall W; Hammond D
    Psychopharmacology (Berl); 2022 May; 239(5):1509-1519. PubMed ID: 35020045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported Impact of the COVID-19 Pandemic on Cannabis Use in Canada and the United States.
    Wadsworth E; Goodman S; Hammond D
    J Psychoactive Drugs; 2023; 55(4):483-492. PubMed ID: 35981105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status.
    Rup J; Freeman TP; Perlman C; Hammond D
    Addict Behav; 2021 Oct; 121():106991. PubMed ID: 34087766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of depressive symptoms and cannabis use among adult cigarette smokers in Canada: cross-sectional findings from the 2020 International Tobacco Control Policy Evaluation Project Canada Smoking and Vaping Survey.
    Gravely S; Driezen P; McClure EA; Smith DM; Fong GT
    CMAJ Open; 2023; 11(3):E516-E526. PubMed ID: 37311596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and outcomes of prenatal recreational cannabis use in high-income countries: a scoping review.
    Singh S; Filion KB; Abenhaim HA; Eisenberg MJ
    BJOG; 2020 Jan; 127(1):8-16. PubMed ID: 31529594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cannabis use and the frequency, types, and sources of cannabis products used in northern remote territories of the Canadian legal cannabis market.
    Hobin E; Schwartz N; Poon T; Hammond D
    Can J Public Health; 2024 Aug; 115(4):628-638. PubMed ID: 38760617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Hammond D
    Drug Alcohol Depend; 2022 Feb; 231():109262. PubMed ID: 34998249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and Mental Health: Adverse Outcomes and Self-Reported Impact of Cannabis Use by Mental Health Status.
    Rup J; Freeman TP; Perlman C; Hammond D
    Subst Use Misuse; 2022; 57(5):719-729. PubMed ID: 35170396
    [No Abstract]   [Full Text] [Related]  

  • 18. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.
    Hall W; Stjepanović D; Caulkins J; Lynskey M; Leung J; Campbell G; Degenhardt L
    Lancet; 2019 Oct; 394(10208):1580-1590. PubMed ID: 31657733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public health impacts to date of the legalisation of medical and recreational cannabis use in the USA.
    Chiu V; Leung J; Hall W; Stjepanović D; Degenhardt L
    Neuropharmacology; 2021 Aug; 193():108610. PubMed ID: 34010617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of trends in the prevalence of cannabis use and related metrics in Canada.
    Rotermann M
    Health Rep; 2019 Jun; 30(6):3-13. PubMed ID: 31216047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.